Key Points
MUMBAI: Cipla said it expects to end FY24 with the earnings before interest, tax, depreciation and ammortisation (Ebitda) margins of 24%, making it the drugmaker's highest ever margins led by sustained US and India sales momentum..
Cipla's Ebitda margin expanded 230 basis points yoy to 26.3% in Q3FY24 while in the first nine months the Ebitda stood with Ebitda margins of around 25.3%...
The fourth quarter has always been the lowest, so that impacts our margins," Umang Vohra MD and Global CEO of Cipla, said in a post-earnings media call...
You might be interested in
Pharma Q2 Preview: Cipla to see steady quarter; higher profit and revenue growth for Dr Reddy's
26, Oct, 23Cipla could deliver healthy growth of 5% in the Indian business in the second quarter, but the US business is likely to witness pressure on account of lower Albuterol Sulphate sales. Revenue for the quarter is likely to grow at 13% year-on-year (YoY), according to an average estimate of three brokerages, and net profit for the same period is expected to rise around 19% YoY.
ITC Q3 preview: Net profit likely to rise over 3%, revenue up by 5%
28, Jan, 24The conglomerate is likely to post a net profit of approximately ₹5,183 crore for the current quarter, reflecting a 3 percent increase compared to the corresponding quarter in the previous fiscal year.
India shines in Coca-Cola’s global sales in the September quarter
24, Oct, 23The global beverages giant says superior sales in India lifted its sales during the July-September quarter…
Cipla Q3 Results: Profit jumps 32% YoY to Rs 1,056 crore, revenue rises 14%
22, Jan, 24Cipla's Q3 revenue for the quarter grew 13.7% YoY to Rs 6,604 crore, compared to Rs 5,810 crore in the same quarter last year. However, the drugmaker saw a marginal decline from the previous quarter's revenue of Rs 6,678 crore. Meanwhile, its EBITDA surged 24.2% YoY to Rs 1,748 crore in the December quarter of FY24.
Nestle Q1 Preview: Revenue likely to rise 12-15% YoY on price hikes; volume growth to be muted
24, Apr, 23Nestle India is expected to have double-digit revenue growth between January to March 2022, however, it is anticipated that price hikes will be the main contributor, whilst the underlying volume growth remains slow at 3%. Despite the positive figures, gross and EBITDA margins are expected to fall due to a rise of inflation on essential input prices compared to the previous year. Analysts have predicted the company's revenue growth at 14.5% with an EBITDA margin of 22.8%. Nestle India will report its Q1 results on April 25.
Cipla Q2 Results: Profit jumps 43% YoY to Rs 1,131 crore, revenue rises 15%
27, Oct, 23The bottomline was higher than the Rs 1,006 crore which was expected by analysts in an ET Now poll. Cipla's consolidated margin came in at 26% during the quarter.